Navigation Links
R&D and Demand Draw Medical Biotech Companies and Device Makers to Germany

R&D and Demand Draw Medical Biotech Companies and Device Makers to Germany -- BERLIN, November 3, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Medical Pharmaceuticals, Economic News, Trends, Analysis Click to view news release full screen  

R&D and Demand Draw Medical Biotech Companies and Device Makers to Germany


BERLIN, November 3, 2010 /PRNewswire/ -- Demand for medical biotechnology in Germany grew in 2009, further proving that the economic crisis has been well managed by Europe's largest economy. Revenue in medical biotechnology has increased for a fifth consecutive year, coming in at over EUR 5.7 billion in 2009. This coincides with strong innovation, as hundreds of projects have been realized thanks to cooperation with R&D institutes in Germany. Germany Trade & Invest will have representatives on hand at this year's Open Innovation - Global Strategies in R&D conference on November 4-5 in Boston to share opportunities for American companies in Germany's medical biotechnology and medical device industries.

The importance of R&D for the future of these industries is confirmed by generous funding. At almost EUR 1 billion in 2009, research funding for medical technology remained constant despite the economic downturn. Companies active in the so-called red biotechnology segment are already utilizing Germany's innovative R&D infrastructure, with over 800 cooperation projects with R&D institutes in Germany reported last year. This network of partners facilitates innovation across the entire value chain. Cooperation with other companies, research institutions, and organizations is common, especially for small companies.

Over three quarters of German biotech companies have less than 30 employees. This industry structure allows for international companies of all sizes to easily enter the largest and strongest market in Europe and serve growing demand. Germany's infrastructure, ranked first worldwide by a 2010 World Bank study, enables companies to effectively serve the single European market from Germany.

With over 11,000 companies and 170,000 employees in the medical device industry and several hundred companies working in medical biotechnology, these healthcare industry segments are essential innovation drivers for Germany. Germany is Europe's patent leader with twice the share of registered patents as France and the UK combined. In 2009 German companies were granted over 11,000 patents at the European patent office.

Germany Trade & Invest representatives will be at this year's Open Innovation - Global Strategies in R&D conference in Boston, Massachusetts on November 4-5, 2010. Matchmaking with medical biotechnology and medical device companies will take place with the support of local partners Massachusetts Biotechnology Council (MassBio), Massachusetts Medical Device Industry Council (MassMedic), Massachusetts Life Sciences Center, and the Massachusetts Office of International Trade & Investment (MOITI). Partners from the regional economic development agencies of the federal states of Berlin (Berlin Partner), Mecklenburg-Vorpommern (Invest in Mecklenburg-Vorpommern), and Saxony-Anhalt (IMG Sachsen-Anhalt) will also highlight opportunities in these innovative regions in Eastern Germany.

Germany Trade & Invest is the foreign trade and inward investment promotion agency of the Federal Republic of Germany. The organization advises foreign companies looking to expand their business activities in the German market. It provides information on foreign trade to German companies that seek to enter foreign markets.

Germany Trade & Invest Robert Scheid Email: T: +49(0)30-200099-170 F: +49(0)30-200099-111

SOURCE Germany Trade and Invest
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Biobanking for Medical R&D: Technology and Market 2010-2025
2. Reportlinker Adds Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
3. BioMed Realty Trust Breaks Ground on 176,000 Square Foot R&D Facility for Isis Pharmaceuticals in Carlsbad, California
4. RIKEN Center for Genomics Medicine Chooses Genedata Expressionist for High Throughput Proteomics R&D
5. US Nanotechnology Instrument Manufacturer Proves the Success of R&D Stimulus
6. Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials
7. Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit
8. Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery
9. UMass Boston Opens Venture Development Center to Expand R&D Activity
10. Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies
11. In-demand Contemporary Research Reports on Biotechnology Markets Available at
Post Your Comments:
(Date:12/1/2015)... -- Cepheid (Nasdaq: CPHD ) today announced that, ... Healthcare Conference in New York City ... outlook for the fourth quarter of 2015 and initiating ... term business model expectations. John Bishop , ... be the fastest growing company of the major market ...
(Date:11/30/2015)... ... November 30, 2015 , ... Global ... practitioners and aesthetics professionals from Central America and abroad for the first Iberoamerican ... City, Panama Feb. 17-19, 2016. Testart will present and discuss new trends in ...
(Date:11/30/2015)... (NYSE: BIOA ), a leader in renewable materials, today ... Climate Pledge, alongside more than 140 companies from across the ... demonstrate an ongoing commitment to climate action and to voice ... Paris climate negotiations. Sarnia, Canada ... --> BioAmber uses biotechnology to convert renewable sugars ...
(Date:11/30/2015)... Nov. 30, 2015 Spherix Incorporated (Nasdaq: ... to the fostering and monetization of intellectual property, ... prospective initiatives designed to create shareholder value. ... of Spherix. "Based on published reports, the total ... $50 billion and Spherix will seek to secure ...
Breaking Biology Technology:
(Date:11/17/2015)... , November 17, 2015 Paris ... 2015.   --> Paris from 17 ... DERMALOG, the biometrics innovation leader, has invented the first ... fingerprints on the same scanning surface. Until now two different ... Now one scanner can capture both on the same ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces today ... its Board of Directors. --> ... recently retiring from the partnership at TPG Capital, one ... with over $140 Billion in revenue.  He founded and ... all the TPG companies, from 1997 to 2013.  In ...
(Date:11/16/2015)... 16, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced expansion of its TDDI product portfolio ... controller and display driver integration (TDDI) solutions designed ... new TDDI products add to the previously-announced ... (WQHD resolution), and TD4322 (FHD resolution) solutions. All ...
Breaking Biology News(10 mins):